JP2017525355A5 - - Google Patents

Download PDF

Info

Publication number
JP2017525355A5
JP2017525355A5 JP2017506963A JP2017506963A JP2017525355A5 JP 2017525355 A5 JP2017525355 A5 JP 2017525355A5 JP 2017506963 A JP2017506963 A JP 2017506963A JP 2017506963 A JP2017506963 A JP 2017506963A JP 2017525355 A5 JP2017525355 A5 JP 2017525355A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid molecule
molecule according
regulatory sequence
operably linked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017506963A
Other languages
English (en)
Japanese (ja)
Other versions
JP6616822B2 (ja
JP2017525355A (ja
Filing date
Publication date
Priority claimed from GBGB1414130.3A external-priority patent/GB201414130D0/en
Application filed filed Critical
Publication of JP2017525355A publication Critical patent/JP2017525355A/ja
Publication of JP2017525355A5 publication Critical patent/JP2017525355A5/ja
Application granted granted Critical
Publication of JP6616822B2 publication Critical patent/JP6616822B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017506963A 2014-08-08 2015-08-11 バクテリオファージ・ラムダ・インテグラーゼの変異体 Active JP6616822B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1414130.3A GB201414130D0 (en) 2014-08-08 2014-08-08 Mutants of the bacteriophage lambda integrase
GB1414130.3 2014-08-08
PCT/SG2015/050255 WO2016022075A1 (en) 2014-08-08 2015-08-11 Mutants of the bacteriophage lambda integrase

Publications (3)

Publication Number Publication Date
JP2017525355A JP2017525355A (ja) 2017-09-07
JP2017525355A5 true JP2017525355A5 (enExample) 2018-09-13
JP6616822B2 JP6616822B2 (ja) 2019-12-04

Family

ID=51629549

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017506963A Active JP6616822B2 (ja) 2014-08-08 2015-08-11 バクテリオファージ・ラムダ・インテグラーゼの変異体

Country Status (7)

Country Link
US (2) US10344301B2 (enExample)
EP (1) EP3177717A4 (enExample)
JP (1) JP6616822B2 (enExample)
CN (1) CN108064279B (enExample)
GB (1) GB201414130D0 (enExample)
SG (2) SG11201700955SA (enExample)
WO (1) WO2016022075A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201414130D0 (en) * 2014-08-08 2014-09-24 Agency Science Tech & Res Mutants of the bacteriophage lambda integrase
GB201603577D0 (en) * 2016-03-01 2016-04-13 Oxford Genetics Ltd Promoter
US11078493B2 (en) 2016-06-21 2021-08-03 Nanyang Technological University Site-specific DNA recombination
EP3638776B1 (en) 2017-06-14 2025-11-05 Technische Universität Dresden Methods and means for genetic alteration of genomes utilizing designer dna recombining enzymes
CA3149188A1 (en) * 2019-07-29 2021-02-04 The Trustees Of Indiana University Materials and methods for treating friedreich's ataxia
AU2020391489A1 (en) 2019-11-25 2022-06-09 Larimar Therapeutics, Inc. Methods for quantifying frataxin activity
EP4142768A1 (en) 2020-04-30 2023-03-08 Larimar Therapeutics, Inc. Methods for treating myelin associated diseases and mitochondria associated diseases
EP4259183A1 (en) 2020-12-12 2023-10-18 Larimar Therapeutics, Inc. Pharmaceutical composition comprising frataxin fusion protein and methods of use thereof
EP4305177A4 (en) * 2021-03-12 2024-12-25 Nanyang Technological University METHOD FOR PRODUCING SEAMLESS DNA VECTORS
WO2023234866A1 (en) * 2022-05-31 2023-12-07 Nanyang Technological University Method for production of a eukaryotic host cell or cell line for lambda-integrase-mediated recombination
CN118546903A (zh) * 2023-02-24 2024-08-27 尧唐(上海)生物科技有限公司 能介导大片段dna整合到哺乳动物基因组的酶及其应用
WO2024181932A1 (en) * 2023-03-02 2024-09-06 Nanyang Technological University Lambda integrase mutants and methods of their use
WO2025006468A2 (en) 2023-06-26 2025-01-02 University Of Hawaii Evolved integrases and methods of using the same for genome editing

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4489424B2 (ja) * 2001-05-30 2010-06-23 グラクソ グループ リミテッド 染色体に基くプラットホーム
CA2522166C (en) * 2001-05-30 2011-05-03 Chromos Molecular Systems, Inc. Lambda integrase mutein for use in recombination
BRPI0922084B1 (pt) * 2008-11-11 2020-12-29 Danisco Us Inc. variante de subtilisina isolada de uma subtilisina de bacillus e sua composição de limpeza
SG170652A1 (en) 2009-11-06 2011-05-30 Agency Science Tech & Res Muteins of the bacteriophage lambda integrases
GB201414130D0 (en) * 2014-08-08 2014-09-24 Agency Science Tech & Res Mutants of the bacteriophage lambda integrase

Similar Documents

Publication Publication Date Title
JP2017525355A5 (enExample)
JP2016065085A5 (enExample)
JP2015520667A5 (enExample)
JP2016522122A5 (enExample)
JP2016502162A5 (enExample)
JP2016525888A5 (enExample)
DK3230281T3 (da) 1,3-thiazol-2-yl-substituerede benzamider
JP2017137500A5 (enExample)
LT3701971T (lt) Junginiai, naudingi hibridinio imunoglobulino, turinčio nepeptidilo ryšį, gamyboje
EA201790505A1 (ru) Соединение, нацеленое на ил-23а и фно-альфа, и его применение
JP2015057496A5 (enExample)
JP2015201986A5 (enExample)
JP2016130150A5 (ja) 車両用リフト装置
DK3107649T3 (da) Katalytisk fremgangsmåde, der omfatter to konsekutive reaktionszoner
BR112016024805A2 (pt) produção assistida pelo modelo de materiais porosos.
JP2016053220A5 (enExample)
JP2016047837A5 (enExample)
JP2017516883A5 (enExample)
JP2015168758A5 (enExample)
JP2015108025A5 (enExample)
BR112017007751A2 (pt) Processo para a preparação de 5-bromo-1,2,3- triclorobenzeno.
FR3030308B1 (fr) Distillation reactive photocatalytique.
JP2017022663A5 (enExample)
ES1136607Y (es) Barril decorativo multiuso.
TH1501004260A (th) กระบวนการสำหรับการผลิตสารผสมของตัวเร่งปฏิกิริยาซึ่งมีการไหลที่ถูกปรับปรุง